PEAK6 Investments »

Bridgebio Pharma shares owned by PEAK6 Investments

Quarter-by-quarter ownership of Bridgebio Pharma (BBIO) shares owned by PEAK6 Investments from 13F filings

Historical chart of PEAK6 Investments investment in Bridgebio Pharma

Tip: Access up to 7 years of quarterly data

All positions including Bridgebio Pharma held by PEAK6 Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bridgebio Pharma by PEAK6 Investments

Quarter filed Position value Share count Share price at filing
2023-09-30 $2.6M 98k 26.37
2023-06-30 $172k 10k 17.20
2022-06-30 $172k 10k 17.20
2020-12-31 $917k 13k 71.09

More positions owned by PEAK6 Investments

SPDR S&P 500 ETF TR Tr Unit Call Option (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Tesla Motors Call Option (TSLA)
NVIDIA Corporation Call Option (NVDA)
Meta Platforms Cl A Call Option (META)
Apple Call Option (AAPL)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Adobe Systems Incorporated Call Option (ADBE)
Amazon Call Option (AMZN)
Broadcom Call Option (AVGO)
Netflix Call Option (NFLX)
Alibaba Group Hldg Sponsored Ads Call Option (BABA)
Pdd Holdings Sponsored Ads Call Option (PDD)
MercadoLibre Call Option (MELI)
Citigroup Com New Call Option (C)

View all positions for PEAK6 Investments

Top funds holding Bridgebio Pharma

Kohlberg Kravis Roberts & Co
Viking Global Investors
Vanguard Group
Aisling Capital Management
Laurion Capital Management
Cormorant Asset Management
Goldman Sachs Group
Lord, Abbett & Co
Frazier Life Sciences Management
Alliancebernstein
Perceptive Advisors
Citigroup
Wellington Management Company
Hillhouse Capital Advisors
Norges Bank Investment Management

View all funds holding Bridgebio Pharma